Nokea
All of the following are potential causes of elevated LDL , except:
- A. Cirrhosis
- B. Hypothyroidism
- C. Nephrotic syndrome
- D. Thiazide diuretics
Correct Answer: A
Rationale: Cirrhosis is not a potential cause of elevated LDL cholesterol levels. The liver plays a significant role in cholesterol metabolism, and liver disease like cirrhosis can actually lead to decreased levels of LDL cholesterol. Elevated LDL cholesterol levels can be caused by conditions such as hypothyroidism, nephrotic syndrome, or the use of certain medications like thiazide diuretics.
You may also like to solve these questions
Karyotype 47, XYY is:
- A. True hermaphroditism
- B. Supermale
- C. Klinefelter's syndrome
- D. Gonadal dysgenesis
Correct Answer: B
Rationale: Karyotype 47, XYY refers to the presence of an extra Y chromosome in males. This condition is known as XYY syndrome, also called Jacob's syndrome. Individuals with XYY syndrome are typically phenotypically male but may have some associated physical and behavioral characteristics. These individuals are often referred to as "supermales" due to the presence of the extra Y chromosome. This is different from true hermaphroditism, Klinefelter's syndrome, and gonadal dysgenesis, which have distinct chromosomal patterns and manifestations.
Excess prolactin causes:
- A. Acromegaly
- B. Gynecomastia
- C. Dwarfism
- D. Early Menopause
Correct Answer: B
Rationale: Excess prolactin typically causes gynecomastia in men. Prolactin is a hormone primarily responsible for milk production in women. However, in men, elevated levels of prolactin can lead to various symptoms, with gynecomastia being one of the most common. Gynecomastia is the development of breast tissue in males, which can result in swelling and tenderness of the breasts. It is important to investigate the underlying cause of elevated prolactin levels as it could be due to various conditions such as pituitary tumors, certain medications, or thyroid disorders.
Myxoedema coma is characterized by:
- A. Hypertension
- B. Tachycardia
- C. Euthermia
- D. Hypoventilation
Correct Answer: B
Rationale: Myxoedema coma is a severe form of hypothyroidism that can lead to the slowing down of various body functions, including reduced heart rate (bradycardia). As the condition progresses and the body's metabolism becomes more depressed, one of the compensatory mechanisms is an increase in heart rate (tachycardia) to try to maintain adequate tissue perfusion. Therefore, tachycardia is a characteristic feature of myxoedema coma, rather than hypertension or euthermia which are not typically associated with this condition. Hypoventilation is also a common feature of myxoedema coma due to the decreased metabolic rate and respiratory drive.
Phaeochromocytoma is not associated with:
- A. Weight gain
- B. Fear of death (angor animi)
- C. Paroxysmal hypertension
- D. Constipation
Correct Answer: A
Rationale: Phaeochromocytoma is a rare neuroendocrine tumor that usually originates from the adrenal glands and produces excess catecholamines. The characteristic symptoms of phaeochromocytoma include paroxysmal (sudden and severe) hypertension, fear of impending death (angor animi), and episodic symptoms like palpitations, headache, and diaphoresis. However, weight gain is not a typical manifestation associated with phaeochromocytoma. In fact, patients with this condition may experience unintentional weight loss due to the effects of excess catecholamines on metabolism and appetite suppression. Therefore, weight gain is not a significant feature observed in individuals with phaeochromocytoma.
The receptors for non-steroid peptide hormones are found on the ______.
- A. plasma membrane
- B. nuclear envelope
- C. mitochondria
- D. lysosomes
Correct Answer: A
Rationale: The receptors for non-steroid peptide hormones are typically found on the plasma membrane of target cells. These hormones are large or polar molecules that cannot easily diffuse through the cell membrane. Instead, they bind to specific receptors on the cell surface, initiating signaling pathways that eventually lead to changes within the cell. Once the peptide hormone binds to its receptor on the plasma membrane, secondary messenger systems are activated to relay the signal into the cell and initiate the appropriate cellular response. This distinct mechanism of action highlights the importance of the plasma membrane as the location of receptors for non-steroid peptide hormones.